readthroughSign in
CompanyXLONasdaqWaltham, MA

Xilio Therapeutics, Inc.

Xilio Therapeutics develops masked immuno-oncology therapies designed to activate selectively within the tumor microenvironment.

SCHEDULE 13GNov 16Latest SEC filing
Nov 10Latest story